Mirae Asset Global Investments Co. Ltd. Increases Holdings in Mettler-Toledo International, Inc. $MTD

Mirae Asset Global Investments Co. Ltd. grew its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 7.7% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,680 shares of the medical instruments supplier’s stock after acquiring an additional 192 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Mettler-Toledo International were worth $3,148,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the stock. Robeco Institutional Asset Management B.V. grew its stake in shares of Mettler-Toledo International by 83.0% in the second quarter. Robeco Institutional Asset Management B.V. now owns 69,973 shares of the medical instruments supplier’s stock worth $82,199,000 after acquiring an additional 31,736 shares during the last quarter. Pacific Point Advisors LLC grew its stake in shares of Mettler-Toledo International by 7.3% in the second quarter. Pacific Point Advisors LLC now owns 1,151 shares of the medical instruments supplier’s stock worth $1,352,000 after acquiring an additional 78 shares during the last quarter. V Square Quantitative Management LLC grew its stake in shares of Mettler-Toledo International by 3.7% in the second quarter. V Square Quantitative Management LLC now owns 559 shares of the medical instruments supplier’s stock worth $657,000 after acquiring an additional 20 shares during the last quarter. Sound Income Strategies LLC grew its stake in shares of Mettler-Toledo International by 477.8% in the second quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after acquiring an additional 43 shares during the last quarter. Finally, Crown Oak Advisors LLC grew its stake in shares of Mettler-Toledo International by 1.6% in the second quarter. Crown Oak Advisors LLC now owns 6,035 shares of the medical instruments supplier’s stock worth $7,089,000 after acquiring an additional 93 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

MTD has been the topic of a number of recent research reports. Robert W. Baird increased their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Bank of America upped their price target on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd. Barclays lifted their price objective on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the stock an “overweight” rating in a report on Thursday, October 2nd. Weiss Ratings restated a “hold (c)” rating on shares of Mettler-Toledo International in a research note on Saturday, September 27th. Finally, Citigroup lifted their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research note on Thursday, August 21st. Five research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $1,342.22.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock opened at $1,305.67 on Wednesday. The stock has a market cap of $26.90 billion, a PE ratio of 33.06, a price-to-earnings-growth ratio of 4.04 and a beta of 1.37. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,486.76. The stock has a fifty day moving average of $1,274.75 and a 200 day moving average of $1,187.87.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. The company had revenue of $983.22 million during the quarter, compared to analysts’ expectations of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.Mettler-Toledo International’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, sell-side analysts predict that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Insider Activity at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the transaction, the chief financial officer directly owned 5,095 shares in the company, valued at approximately $6,750,875. The trade was a 5.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total value of $215,925.60. Following the transaction, the insider owned 94 shares in the company, valued at $123,012.16. This trade represents a 63.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 1,827 shares of company stock worth $2,371,208. 0.77% of the stock is owned by insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.